A Disintegrin and Metalloproteinase 17 is required for ILC2 responses to IL-33.

[1]  R. Germain,et al.  S1P-dependent interorgan trafficking of group 2 innate lymphoid cells supports host defense , 2018, Science.

[2]  D. Conrad,et al.  ADAM10-Mediated ICOS Ligand Shedding on B Cells Is Necessary for Proper T Cell ICOS Regulation and T Follicular Helper Responses , 2017, The Journal of Immunology.

[3]  D. Voehringer,et al.  IL-27 suppresses type 2 immune responses in vivo via direct effects on group 2 innate lymphoid cells , 2016, Mucosal Immunology.

[4]  D. Conrad,et al.  Increased B Cell ADAM10 in Allergic Patients and Th2 Prone Mice , 2015, PloS one.

[5]  Xi Chen,et al.  IL-25-responsive, lineage-negative KLRG1hi cells are multipotential “inflammatory” type 2 innate lymphoid cells , 2014, Nature Immunology.

[6]  G. Freund,et al.  IL-1 receptor 2 (IL-1R2) and its role in immune regulation , 2013, Brain, Behavior, and Immunity.

[7]  J. Scheller,et al.  The membrane‐proximal domain of A Disintegrin and Metalloprotease 17 (ADAM17) is responsible for recognition of the interleukin‐6 receptor and interleukin‐1 receptor II , 2012, FEBS letters.

[8]  A. McKenzie,et al.  Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity , 2010, Nature.

[9]  茂呂 和世.  Innate production of T[H]2 cytokines by adipose tissue-associated c-Kit[+]Sca-1[+] lymphoid cells , 2010 .

[10]  Tsutomu Takeuchi,et al.  Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells , 2009, Nature.

[11]  A. Ludwig,et al.  The good, the bad and the ugly substrates for ADAM10 and ADAM17 in brain pathology, inflammation and cancer. , 2009, Seminars in cell & developmental biology.

[12]  C. Dinarello,et al.  Immunological and inflammatory functions of the interleukin-1 family. , 2009, Annual review of immunology.

[13]  R. Kastelein,et al.  IL-1 Receptor Accessory Protein and ST2 Comprise the IL-33 Receptor Complex , 2007, The Journal of Immunology.

[14]  Niamh E Mangan,et al.  Identification of an interleukin (IL)-25–dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion , 2006, The Journal of experimental medicine.

[15]  D. O'Leary,et al.  Dynamic Patterned Expression of Orphan Nuclear Receptor Genes RORα and RORβ in Developing Mouse Forebrain , 2003, Developmental Neuroscience.

[16]  R. Coffman,et al.  New IL-17 Family Members Promote Th1 or Th2 Responses in the Lung: In Vivo Function of the Novel Cytokine IL-251 , 2002, The Journal of Immunology.

[17]  D. Neumann,et al.  The Membrane Form of the Type II IL-1 Receptor Accounts for Inhibitory Function1 , 2000, The Journal of Immunology.

[18]  D. Boraschi,et al.  The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness. , 1998, Journal of immunology.

[19]  A. H. Drummond,et al.  Role of Metalloproteases in the Release of the IL-1 type II Decoy Receptor* , 1997, The Journal of Biological Chemistry.

[20]  P. Feng,et al.  IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. , 1997, Science.

[21]  M. Lambert,et al.  Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α , 1997, Nature.

[22]  M. Labow,et al.  Molecular Cloning and Characterization of a Second Subunit of the Interleukin 1 Receptor Complex (*) , 1995, The Journal of Biological Chemistry.

[23]  A. Mantovani,et al.  The type II 'decoy' receptor: a novel regulatory pathway for interleukin 1. , 1994, Immunology today.

[24]  A. Mantovani,et al.  Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. , 1993, Science.